During the past decade, Mercy Clinic Oncology and Hematology conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 4 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 3 clinical trials were completed. i.e. 150% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Mercy Clinic Oncology and Hematology" #1 sponsor was "Novartis Pharmaceuticals" with 2 trials, followed by "Helsinn Healthcare SA" with 1 trials sponsored, "Inivata" with 1 trials sponsored, "Mirati Therapeutics Inc." with 1 trials sponsored and "Northwestern University" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Mercy Clinic Oncology and Hematology" #1 collaborator was "Amgen" with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator, "Clinipace Worldwide" with 1 trials as a collaborator, "Genentech, Inc." with 1 trials as a collaborator and "Guardian Research Network, Inc." with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Mercy Clinic Oncology and Hematology" are "Acute Myeloid Leukemia" (1 trials), "Advanced or Metastatic Gastric or Gastroesophageal Cancer" (1 trials), "Advanced or Metastatic Solid Tumor" (1 trials), "Advanced, Metastatic Breast Cancer" (1 trials) and "Breast Cancer" (1 trials). Many other conditions were trialed in "Mercy Clinic Oncology and Hematology" in a lesser frequency.

Most popular intervention types in "Mercy Clinic Oncology and Hematology" are "Drug" (8 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Azacitidine" (1 trials), "Capecitabine" (1 trials), "Docetaxel" (1 trials), "Futibatinib" (1 trials) and "LDK378" (1 trials). Other intervention names were less common.

The vast majority of trials in "Mercy Clinic Oncology and Hematology" are 8 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Mercy Clinic Oncology and Hematology". undefined are not yet recruiting, undefined are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Mercy Clinic Oncology and Hematology, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Mercy Clinic Oncology and Hematology, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".